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Abstract: 
Intelligence is a highly heritable trait for which it has proven difficult to identify the actual 
genes. In the past decade, five whole-genome linkage scans have suggested genomic regions 
important to human intelligence; however, so far none of the responsible genes or variants in 
those regions have been identified. Apart from these regions, a handful of candidate genes have 
been identified, although most of these are in need of replication. The recent growth in publicly 
available data sets that contain both whole genome association data and a wealth of phenotypic 
data, serves as an excellent resource for fine mapping and candidate gene replication. We used 
the publicly available data of 947 families participating in the International Multi-Centre ADHD 
Genetics (IMAGE) study to conduct an in silico fine mapping study of previously associated 
genomic locations, and to attempt replication of previously reported candidate genes for 
intelligence. Although this sample was ascertained for attention deficit/hyperactivity disorder 
(ADHD), intelligence quotient (IQ) scores were distributed normally. We tested 667 single 
nucleotide polymorphisms (SNPs) within 15 previously reported candidate genes for intelligence 
and 29451 SNPs in five genomic loci previously identified through whole genome linkage and 
association analyses. Significant SNPs were tested in four independent samples (4,357 subjects), 
one ascertained for ADHD, and three population-based samples. Associations between 
intelligence and SNPs in the ATXN1 and TRIM31 genes and in three genomic locations showed 
replicated association, but only in the samples ascertained for ADHD, suggesting that these 
genetic variants become particularly relevant to IQ on the background of a psychiatric disorder.  
genetic association | cognition | candidate genes | ADHD | ALSPAC | intelligence | Keywords: 
psychology | medical genetics 
Article: 
INTRODUCTION 
Intelligence is a highly heritable complex trait, for which it is hypothesized that many genes of 
small effect size contribute to its variability [McClearn et al., 1997; Plomin, 1999]. Almost a 
decade after the completion of a rough draft of the human genome sequence, major efforts have 
been undertaken to identify common variations related to inter-individual differences in 
intelligence. Plomin and coworkers [Plomin, 1999; Plomin et al., 2001, 2004; Butcher et al., 
2005, 2008] conducted several genome wide association (GWA) studies and showed significant 
association of a functional polymorphism in ALDH5A1 (aldehyde dehydrogenase 5 family) 
(MIM: 610045) on chromosome 6p with intelligence. Whole genome linkage scans for 
intelligence [Posthuma et al., 2005; Buyske et al., 2006; Dick et al., 2006; Luciano et al., 2006] 
reported two areas of genome-wide significant linkage for general intelligence on the long arm of 
chromosome 2 (2q24.1-31.1) and the short arm of chromosome 6 (6p25-21.2), and several areas 
of suggestive linkage (4p, 7q, 14q, 20p, 21p), following Lander and Kruglyak guidelines [1995]. 
The region on chromosome 6 (6p25-21.2) overlaps with the locus (6p24.1) identified in the 
genome-wide association study performed by Butcher et al. [2008]. Converging evidence from 
these whole genome studies provides support for the involvement of six different chromosomal 
regions, 2q24.1-31.1, 2q31.3, 6p25-21.2, 7q32.1, 14q11.2-12, and 16p13.3, in human 
intelligence (see Table I). 
 
Table I. Summary of Genomic Loci Previously Associated With Intelligence 
Locus Refs. Previous population 
2q24.1-31.1 Posthuma et al. [2005] Study = 1, population = 1 and 2, N = 950 
  Luciano et al. [2006] Study = 1, population = 1 and 2, N = 836 
2q31.3 Butcher et al. [2008] Study = 1, population = 3, N = 3,195 
6p25-21.2 Posthuma et al. [2005] Study = 1, population = 1 and 2, N = 950 
Locus Refs. Previous population 
  Luciano et al. [2006] Study = 1, population = 1 and 2, N = 836 
7q32.1 Butcher et al. [2008] Study = 1, population = 3, N = 3,195 
14q11.2-12 Buyske et al. [2006] Study = 2, population = 1, N = 1,115 
16p13.3 Butcher et al. [2008] Study = 1, population = 3, N = 3,195 
Study 1 is a family study, 2 is the COGA (Collaborative Studies on Genetics of Alcoholism) 
family study. Population 1 is from the Netherlands, 2 is from Australia, 3 is from the United 
Kingdom. 
N indicates sample size. 
Apart from whole genome searches, several candidate gene-based association analyses have also 
reported significant associations with human intelligence [for a review see Posthuma and de 
Geus, 2006]. Based on a literature search, we identified 16 genes that have been associated with 
intelligence, as measured with an intelligence quotient test (IQ) at least once (P-value ≤0.05); 
DTNBP1 (dystrobrevin-binding protein 1) (MIM: 607145), ALDH5A1 (aldehyde dehydrogenase 
5 family, member A1) (MIM: 610045), IGF2R (insulin-like growth factor 2 receptor) (MIM: 
147280), CHRM2 (cholinergic muscarinic receptor 2) (MIM: 118493), BDNF (brain-derived 
neurotrophic factor) (MIM: 113505), CTSD (cathepsin D) (MIM: 116840), DRD2 (dopamine 
receptor D2) (MIM: 126450), KL (klotho) (MIM: 604824), APOE (apolipoprotein E) (MIM: 
107741), SNAP25 (synaptosomal-associated protein, 25 kDa) (MIM: 600322), PRNP (prion 
protein (p27-30)) (MIM: 176640), CBS (cystathionine-beta-synthase) (MIM: 236200), COMT 
(catechol-O-methyltransferase) (MIM: 116790), DNAJC13 (DnaJ (Hsp40)) (GeneID: 23317), 
FADS3 (fatty acid desaturase 3) (MIM: 606150), and TBC1D7 (TBC1 domain family, member 
7) (GeneID: 51256) (see Table II). 
 
 
 
 
 
Table II. Overview of Genes Previously Associated With Intelligence at Least Once 
Gene Chr Gene 
size 
SNP Position Type Previous P-
value 
Refs. Previous 
population 
DNAJC13 3 121371 rs1378810 133736780 Intron 0.0007 
Butcher et al. 
[2008] 
Study = 3, 
population = 5, 
N = 3,195 
TBC1D7 6 35001 rs2496143 13419830 Intron 0.037 
Butcher et al. 
[2008] 
Study = 3, 
population = 5, 
N = 3,195 
DTNBP1 6 140233 rs1018381 15765048 Intron 0.008 
Burdick et al. 
[2006a, b] 
Study = 1, 
population = 1, 
N = 339 
ALDH5A1 6 42238 rs2760118 24611568 
Coding-non-
synonymous 0.001 
Plomin et al. 
[2004] 
Study = 4, 
population = 1, 
N = 594 
IGF2R 6 137452 rs3832385 160446894 mrna-utr 0.02 
Chorney et 
al. [1998] 
Study = 4, 
population = 1, 
N = 102 
CHRM2 7 148372 rs8191992 136351847 mrna-utr <0.017 
Comings et 
al. [2003] 
Study = 4, 
population = 1, 
N = 828 
Gene Chr 
Gene 
size SNP Position Type 
Previous P-
value Refs. 
Previous 
population 
      rs8191992 136351847 mrna-utr 0.036 
Dick et al. 
[2007] 
Study = 2, 
population = 1, 
N = 1,113 
      rs1378650 136355690 — 0.028 
Dick et al. 
[2007] 
Study = 2, 
population = 1, 
N = 1113 
      rs1424548 136360299 — 0.037 
Dick et al. 
[2007] 
Study = 2, 
population = 1, 
N = 1113 
      rs2350780 136243508 Intron 0.016 
Dick et al. 
[2007] 
Study = 2, 
population = 1, 
N = 1113 
      rs2350786 136327109 Intron 0.016 
Dick et al. 
[2007] 
Study = 2, 
population = 1, 
N = 1113 
      rs6948054 136331340 Intron 0.04 
Dick et al. 
[2007] 
Study = 2, 
population = 1, 
N = 1113 
      rs7799047 136322097 Intron 0.02 Dick et al. 
[2007] 
Study = 2, 
population = 1, 
Gene Chr 
Gene 
size SNP Position Type 
Previous P-
value Refs. 
Previous 
population 
N = 1113 
      rs324640 136339535 Intron <0.001 
Gosso et al. 
[2006b] 
Study = 3, 
population = 2, 
N = 667 
      rs324650 136344200 Intron <0.01 
Gosso et al. 
[2006b] 
Study = 3, 
population = 2, 
N = 667 
      rs2061174 136311939 Intron <0.01 
Gosso et al. 
[2007] 
Study = 3, 
population = 2, 
N = 762 
      rs2061174 136311939 Intron 0.016 
Dick et al. 
[2007] 
Study = 2, 
population = 1, 
N = 1113 
BDNF 11 66856 rs6265 27636491 
Coding-non-
synonymous 0.046 
Tsai et al. 
[2004] 
Study = 4, 
population = 3, 
N = 114 
      rs6265 27636491 
Coding-non-
synonymous 0.001 
Harris et al. 
[2006] 
Study = 4, 
population = 4, 
N = 904 
Gene Chr 
Gene 
size SNP Position Type 
Previous P-
value Refs. 
Previous 
population 
CTSD 11 11237 rs17571 1739169 
Coding-non-
synonymous 
0.01 
Payton et al. 
[2006] 
Study = 4, 
population = 1, 
N = 767 
FADS3 11 91903 rs174455 61412693 Intron 0.013 
Butcher et al. 
[2008] 
Study = 3, 
population = 5, 
N = 3195 
DRD2 11 65564 rs2075654 112794275 Intron 0.05 
Gosso et al. 
[2008a] 
Study = 3, 
population = 2, 
N = 762 
KL 13 49708 rs9536314 32526137 
Coding-non-
synonymous 
0.011 
Deary et al. 
[2005] 
Study = 4, 
population = 4, 
N = 915 
APOE 19 3611 rs28931577 50103741 
Coding-non-
synonymous 
0.009 
Deary et al. 
[2002] 
Study = 4, 
population = 4, 
N = 466 
      rs769455 50103879 
Coding-non-
synonymous 
0.009 
Deary et al. 
[2002] 
Study = 4, 
population = 4, 
N = 466 
SNAP25 20 88588 rs362602 10241527 — 0.005 Gosso et al. 
[2006a] 
Study = 3, 
population = 2, 
Gene Chr 
Gene 
size SNP Position Type 
Previous P-
value Refs. 
Previous 
population 
N = 762 
      rs363039 10168495 Intron 0.001 
Gosso et al. 
[2006a] 
Study = 3, 
population = 2, 
N = 762 
      rs363050 10182256 Intron 0.0002 
Gosso et al. 
[2006a] 
Study = 3, 
population = 2, 
N = 762 
PRNP 20 15437 rs1799990 4628250 
Coding-non-
synonymous 0.006 
Kachiwala et 
al. [2005] 
Study = 4, 
population = 4, 
N = 915 
CBS 21 23120 rs5742905 43356252 
Coding-non-
synonymous 0.02 
Barbaux et 
al. [2000] 
Study = 4, 
Population = 1, 
N = 202 
COMT 22 27221 rs4680 18331270 
Coding-non-
synonymous 0.05 
Gosso et al. 
[2008a] 
Study = 3, 
population = 2, 
N = 762 
Study 1 is a control and case schizophrenia study, 2 is the COGA (Collaborative Studies on Genetics of Alcoholism) family study, 3 is 
a family study, 4 is a general population study. Population 1 is from the USA, 2 is from the Netherlands, 3 is from China, 4 is from 
Scotland, 5 is from the UK. 
N indicates sample size.
 
One of the major hurdles in identifying genes for complex traits is the need for replication to 
distinguish false positives from genuine associations. Of all reported genetic association studies 
in the literature, only 4% have shown replicable association according to a 2002 search 
[Hirschhorn et al., 2002]. At present, searching for “genetic” and “association” in PubMed gives 
69950 hits (June 2010), while adding the keywords “replicated” or “validated” results in 1,318 
studies. In other words, in this rough scan around 2.0% of the total reported genetic associations 
are reports of validated genetic association. The field of intelligence shows no exception. Of the 
16 genes mentioned above, only three (CHRM2 [Comings et al., 2003; Gosso et al., 2006b, 
2007; Dick et al., 2007], SNAP25 [Gosso et al., 2006a, 2008b], and BDNF [Tsai et al., 2004; 
Harris et al., 2006]) have shown replicated association with intelligence across independent 
samples. Several other genes (e.g., COMT, DTNBP1) have repeatedly shown association to a 
range of cognitive traits, but have not been replicated for association with intelligence as 
measured with an IQ test [Small et al., 2004; Savitz et al., 2006]. The reasons for lack of 
replication are many and include different ethnicity, insufficient sample size, different 
phenotype, opposite effect direction, or the fact that no replication was attempted at all. 
 
The recent growth in publicly available data sets that contain whole genome association data as 
well as a wealth of phenotypic data serves as an excellent resource for rapid replication efforts. 
In the public domain, the Genetic Association Information Network (GAIN)—International 
Multi-Centre ADHD Genetics (IMAGE) sample is the sole GWA sample with information on IQ 
scores. In the current article, we use data from the IMAGE project, to (a) attempt replication of 
previous association findings for the 16 genes associated with normal intelligence at least once, 
and (b) explore the six chromosome regions previously implicated in human intelligence. 
Associations found in the IMAGE sample (discovery sample) are subsequently attempted for 
replication in four independent samples. Of these four samples one is ascertained for attention 
deficit/hyperactivity disorder (ADHD)—as is the IMAGE sample—and three are population-
based samples. This allows to investigate whether associated single nucleotide polymorphisms 
(SNPs) found with the IMAGE sample are discovered due to an association with intelligence in 
an ADHD population, or are more generally associated with intelligence. 
 
 
MATERIALS AND METHODS 
Primary Sample 
Subjects of the IMAGE project have been described in detail elsewhere [Brookes et al., 2006; 
Kuntsi et al., 2006; Neale et al., 2008]. Briefly, 947 European Caucasian nuclear families (2,844 
individuals) from eight countries (Belgium, England, Germany, Holland, Ireland, Israel, Spain, 
and Switzerland) were included in the analysis. Families had been recruited based on having one 
child with ADHD and another who would provide DNA and quantitative trait data. In addition, 
both parents had to be available for DNA sampling. 
 
IQ scores were available for 606 unrelated probands (for which we also had genotyping data, see 
below), of which 554 were males, with a mean age of 10.99 (SD 2.74). IQ was measured with 
the WISC-III-R (Wechsler Intelligence Scales for children) [Wechsler, 1991] or the WAIS-III-R 
(Wechsler Adult Intelligence Scale) [Wechsler, 1997] when appropriate (for children aged 17 
and older). 
 
The Verbal subtests Vocabulary and Similarities, and the Performance subtests Picture 
Completion and Block Design from the WISC were used to obtain an estimate of a child's IQ 
(prorated following procedures described by Sattler [1992]). Age-appropriate national population 
norms were available for each participating site included in the IMAGE sample and these were 
used to derive standardized estimates of intelligence [Sonuga-Barke et al., 2008]. Standardized 
Full-Scale IQ (FSIQ) scores had a median of 101.6 and a mean of 100.7 (SD 15.7). Skewness of 
the distribution of IQ scores was 0.063 while kurtosis was −0.075. The Shapiro–Wilk test was 
non-significant (P = 0.517) suggesting that the distribution of IQ in the IMAGE sample did not 
deviate form a normal distribution (see Fig. 1). 
 
Figure 1. Density plot for IQ scores in the IMAGE sample. 
 
The parents of the probands filled out the Conner's questionnaire, which provides a quantitative 
measure of ADHD symptoms. Correlations between the symptom scores on the Conner's 
Questionnaire and IQ were −0.066 (P = 0.074.) for the total score, −0.029 (P = 0.442), for the 
inattention score, and −0.084 (P = 0.024) for the hyperactivity/impulsivity score. Although this 
sample was originally ascertained for ADHD, and ADHD and IQ have been reported to be 
associated [Frazier et al., 2004], these findings suggest that in this sample IQ scores are normally 
distributed (as would be expected in a population-based sample) and are at most very weakly 
related to ADHD symptom scores. As there were mean fluctuations across collection sites, we 
calculated Z-scores within each site/country. The use of Z-scores ensures that there are no mean 
IQ differences left across subpopulations in the IMAGE sample and therefore rules out spurious 
associations due to the known subpopulation structure. 
 
Genotyping—Primary Sample 
The IMAGE study was genotyped as part of the GAIN initiative, a public–private partnership of 
the FNIH (Foundation for the National Institutes of Health, Inc.) that currently involves NIH, 
Pfizer, Affymetrix, Perlegen Sciences, Abbott, and the Eli and the Edythe Broad Institute of MIT 
and Harvard University (http://www.fnih.org). Genotyping was conducted at Perlegen Sciences 
using their genotyping platform, which comprises approximately 600,000 tagging SNPs designed 
to be in high linkage disequilibrium with untyped SNPs for the HapMap populations. Genotype 
data were cleaned by NCBI (The National Center for Biotechnology Information). Quality 
control analyses were processed using the GAIN QA/QC Software Package (version 0.7.4) 
developed by Gonçalo Abecasis and Shyam Gopalakrishnan at the University of Michigan. 
Details of the genotyping and data cleaning process for the IMAGE study (study accession 
phs000016.v1.p1) have been reported elsewhere [Neale et al., 2008]. 
 
Briefly, we selected only SNPs with a minor allele frequency (MAF) ≥0.05 and Hardy–
Weinberg equilibrium (HWE) (P ≥ 1 × 10−6). Genotypes causing Mendelian inconsistencies 
were identified by PLINK and removed (http://pngu.mgh.harvard.edu/purcell/plink/) [Purcell et 
al., 2007]. We additionally removed SNPs that failed the quality control metrics for the other two 
GAIN Perlegen studies (i.e., Major Depression Disorder [dbGAP study accession, 
phs000020.v1.p1) and Psoriasis (dbGAP study accession, phs000019.v1.p1), see Neale et al., 
2008]. With this filtering, 384,401 SNPs were retained in the final data set. One genomic 
intelligence locus (7q32.1) could not be included in the analysis because all 10 SNPs inside this 
relatively small area failed the quality control. The APOE was also not included as no SNPs 
were genotyped in or near this gene. Fifteen genes (ALDH5A1, BDNF, CBS, CHRM2, COMT, 
CTSD, DNAJC13, DRD2, DTNBP1, FADS3, IGF2R, KLOTHO, PRNP, SNAP25, and 
TBC1D7) and five genomic areas (2q24.1-31.1, 2q31.3, 6p25-21.2, 14q11.2-12, and 6p13.3) 
were thus included in the association analysis. From the cleaned data set, we selected all 
genotyped SNPs that lie in these candidate genes and genomic loci including 10 kb both 
upstream and downstream of each gene or genomic locus. 
 
Imputation 
To increase coverage in the targeted genomic areas, we used the imputation approach 
implemented in MACH [Li et al., 2006], which imputes genotypes of SNPs that are not directly 
genotyped in the data set, but that are present on a reference panel. MACH is a Markov Chain-
based haplotyper, which obtains an imputation of each unknown genotype using short stretches 
of DNA that are shared among unrelated individuals. The reference panel used was HapMap III 
phased data in MACH input format, which is publicly available for download from the MACH 
website (http://www.sph.umich.edu/csg/abecasis/MaCH/download/). 
 
Genomic coverage of the candidate regions was extended to ∼1.5 Mb common SNPs by 
imputation using the HapMap phase III CEU data (NCBI build 36 (UCSC hg18)) as the 
reference sample. Imputed SNPs were selected if r2 was above 0.3 with the reference allele. 
Additionally, a quality threshold of 0.90 for imputation was set to be included in further 
association testing. 
 
Gene coverage was determined by the sum of the typed and imputed SNPs as well as the tagged 
SNPs (based on HapMap information) divided by the total known common SNPs (again based 
on HapMap information) within a gene, using WGAviewer [Ge et al., 2008]. On average, after 
imputation, gene coverage was 85% in the candidate genes, with 100% coverage for DNAJC13, 
TBC1D7, DTNBP1, ALDH5A1, BDNF, and CTSD. In total, we analyzed 672 SNPs in the 
candidate genes and 29451 SNPs in the genomic loci. 
 
Genetic Association Analysis in IMAGE 
We carried out association testing using an additive linear regression model implemented in 
PLINK for genotyped markers, and in MACH2QTL [Li et al., 2009], for imputed SNPs, taking 
into account dosage information. All IQ scores were precorrected for sex and age and no other 
covariates were included in the model. As mentioned above, Z-scores were calculated within 
each of the different sites included in IMAGE, such that there were no mean differences in IQ 
between sites. Analyses included only SNPs with a minimum 80% genotyping rate and 
individuals with <20% of missing genotype data. SNPs in candidate genes that had a nominal P-
value <0.05, and the top five SNPs from the genomic regions, were selected for testing in the 
four replication samples. 
 
Replication Samples 
Four replication samples totaling 4,357 independent subjects were available for replication of top 
findings of the IMAGE sample. One sample was ascertained for ADHD, and three samples were 
population-based samples. 
 
DUKE cohort 
The DUKE cohort consisted of 216 Americans from 108 families with a DSM-IV diagnosed 
ADHD-affected proband [Kollins et al., 2008]. Families were enrolled from two collection sites: 
Duke University Medical Center, Durham, NC, and University of North Carolina, Greensboro, 
NC. All participating family members provided written informed consent that had been approved 
by the institutional review board at the ascertaining institution. The WAIS-III was administered 
to individuals 17 years of age or older, and the WISC-IV was given to children ages 6–16. The 
Wechsler Preschool and Primary Scale of Intelligence—3rd edition (WPPSI-III) was used for 
children under the age of 6 [Wechsler, 2002]. FSIQ was estimated for both adults and children 
from the vocabulary and block design subtests (M = 109.5 and SD = 12.9). Parents and children 
were genotyped using the Illumina Infinium HumanHap300 duo chip (Illumina, Inc., San Diego, 
CA). Quality of the Illumina data was assessed using PLINK 
(http://pngu.mgh.harvard.edu/purcell/plink/) [Purcell et al. 2007]. SNPs (315,980) were 
submitted for quality checks. Call rates exceeded 98% for all individuals, one individual was 
excluded due to a gender discrepancy, and two individuals were excluded due to per-family 
Mendelian errors in excess of 1%. Out of the 315,980 SNPs submitted, 6,109 SNPs were 
excluded based on a MAF <0.05, 13 SNPs were excluded due to Mendelian errors in >4 families, 
and 629 SNPs were excluded due to deviations from HWE (P < 0.000001). In total, 3 individuals 
and 6,751 SNPs did not pass our quality control checks. Two Centre d'Etude du Polymorphism 
Humain (CEPH) controls and blinded duplicates were used for every 94 samples and required to 
match 100%. Data were genome-wide imputed with the use of the phased data from the HapMap 
samples (CEU; build 36, release 22) and MACH. Association analysis was carried out using 
QTDT (http://www.sph.umich.edu/csg/abecasis/QTDT/). QTDT adopts the between/within 
model as used by Fulker et al. [1999] and Purcell et al. [2007] as implemented in the QFAM 
package. We tested for population stratification by comparing the between and within family 
components of association, using a variant of the orthogonal model [Abecasis et al., 2000]. None 
of the tested SNPs showed sign of stratification in this population. 
 
ALSPAC sample 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a large population-based, 
prospective birth cohort consisting initially of over 13,000 women and their children recruited 
from the Bristol area, UK in the early 1990s [Golding et al., 2001]. ALSPAC has extensive data 
collections on health and development of children and their parents from the 8th gestational 
week onwards. Ethical approval for the study was obtained from the ALSPAC Law and Ethics 
Committee and the local research ethics committees. FSIQ within ALSPAC was measured at the 
age of 8 with the WISC-III [Wechsler et al., 1992]. A short version of the test consisting of 
alternate items only (except the coding task) was applied by trained psychologists [Joinson et al., 
2007]. Verbal (Information, Similarities, Arithmetic, Vocabulary, and Comprehension) and 
Performance (Picture Completion, Coding, Picture arrangement, Block Design, and Object 
assembly) subtests were administered; the subtests were scaled and scores for FSIQ derived. 
ALSPAC (1,543) children were initially genotyped at 317,504 SNPs on the Illumina 
HumanHap317K SNP chip. Individuals exhibiting cryptic relatedness, non-European ancestry, 
high genome-wide heterozygosity, and/or missing rates were excluded as described in Timpson 
et al. [2009], leaving 1,518 individuals in the analysis of whom 1,495 had information on FSIQ 
within a range of ±4 SD (M = 106.8, SD = 15.6). Markers with MAF <1%, SNPs with >5% 
missing genotypes and markers that failed an exact test of HWE (P < 5 × 10−6) were excluded 
from further analyses leaving 310,505 SNPs that passed quality control. GWAS analysis was 
performed on sex and population stratification-adjusted (first five principal components from 
Eigenstrat analysis) [Price et al., 2006] Z-standardized IQ scores. Genome-wide imputation was 
done using the HapMap phase I-II CEU data (release 22, NCBI build 36) as the reference sample 
and MACH software. 
 
QIMR adolescent (Brisbane Adolescent Twin and Family) sample 
The QIMR adolescent cohort is a population-based cohort, consisting of 1,670 Australians (793 
male, 877 female) from 741 families with mean age of 16.4 (SD = 4). FSIQ was assessed with 
the Multidimensional Aptitude Battery [MAB; Jackson, 1984]. Five subtests were administered 
(three Verbal: Information, Arithmetic, Vocabulary; two Performance: Spatial, Object 
Assembly) and from these a standardized FSIQ measure was obtained. FSIQ had a mean of 
112.6 (SD = 12.8). Genotyping was done using the Illumina 610K SNP platform and Illumina 
BeadStudio software, with 529,721 SNPs passing QC. Data were imputed to ∼2.3 million SNPs 
with the use of the phased data from the HapMap samples (CEU; build 36, release 22) and 
MACH.9, described in detail in Medland et al. [2009], (see Project 5: ADOL deCODE). 
Individual SNPs were tested for association with the family-based score test implemented in 
Merlin. This study was approved by the QIMR human research ethics committee and informed 
written consent was obtained from all participants. 
 
Lothian Birth Cohort 1936 (LBC1936) sample 
The LBC1936 consisted of 1,091 individuals who, at the age of ∼11 years, participated in the 
Scottish Mental Survey of 1947, when they took a validated mental ability test, the Moray House 
Test No. 12 (MHT). Briefly, at a mean age of 69.6 years (SD = 0.8) participants of LBC1936 
were recruited to a study to investigate the causes of cognitive ageing. They underwent a series 
of cognitive, physical, and biochemical tests at the Wellcome Trust Clinical Research Facility 
(WTCRF) at the Western General Hospital, Edinburgh. For this study, a general cognitive ability 
factor was derived from principal components analysis of six Wechsler Adult Intelligence Scale-
IIIUK (WAIS-III) subtests (matrix reasoning, letter number sequencing, block design, symbol 
search, digit span backwards, and digit symbol), as described previously [Luciano et al., 2009]. 
The general cognitive ability factor scores were corrected for age in days and sex, and converted 
to IQ scores (mean = 100; SD = 15). DNA was isolated by standard procedure at the WTCRF 
Genetics Core, Western General Hospital, Edinburgh from 1,071 individuals. Twenty-nine 
samples failed quality control preceding the genotyping procedure. The remaining 1,042 samples 
(all blood-extracted) were genotyped at the WTCRF Genetics Core using the Illumina610-
Quadv1 chip. These samples were then subjected to the following quality control procedures 
after which 1,005 samples remained. All individuals were checked for disagreement between 
genetic and reported gender (n = 12). Relatedness between subjects was investigated and, for any 
related pair of individuals, one was removed (n = 8). Samples with a call rate ≤0.95 (n = 16), and 
those showing evidence of non-Caucasian ascent by multidimensional scaling, were also 
removed (n = 1). SNPs were included in the analyses if they met the following conditions: call 
rate ≥0.98, MAF ≥0.01, and HWE test with P ≥ 0.001. The final number of SNPs included in the 
genome-wide association study was 549,091. IQ scores and genotype were available for 976 
individuals. Genomic coverage was extended to ∼2.5 million common SNPs by imputation using 
the HapMap phase II CEU data (NCBI build 36 (UCSC hg18)) as the reference sample and 
MACH software. SNPs with low imputation (r2 < 0.30), low MAF (<0.01), and divergence from 
HWE (P < 0.001) were excluded so that respective SNP and sample call rates were 0.98 and 
0.95. 
 
Statistical power 
The primary (IMAGE) sample of 606 subjects had sufficient (80%) statistical power to detect 
SNPs that explained at least 1.3% of the variance for direct replication (significance level 0.05) 
(Genetic Power Calculator) [Purcell et al., 2003], which is in the order of effect sizes of SNPs 
reported previously. The sample size of the meta-analysis including the two ADHD samples 
(606 + 216 = 822) was sufficient to detect genetic effects explaining 2% of the variance, given a 
Bonferroni corrected significance level of 0.001. The sample size including all samples 
(N = 4,963) was sufficient to detect SNPs explaining 0.35% (i.e., <1%) of the variance 
(significance level of 0.001). 
 
Replication analysis 
All populations were imputed using MACH and imputed SNPs were included in our analysis if 
quality score > 0.9 and r2 > 0.3 and MAF > 0.05. IQ scores were all corrected for effects of age 
and sex and transformed to Z-scores and standardized such that the mean was 100 and SD = 15, 
within each sample, for comparison of effect sizes across samples. 
 
Meta-analysis 
Although replication across different samples provides information on the genuineness of an 
initial association, meta-analysis appropriately weighs the effect and sample sizes across 
different replications samples. We thus conducted a meta-analysis, in which the primary sample 
was included to increase statistical power [Skol et al., 2006]. We used a stepwise approach, in 
which we first ran a combined analysis based on the two samples ascertained for ADHD, and 
then conducted a meta-analysis on all 4,963 subjects. The meta-analysis was conducted using the 
METAL program (http://www.sph.umich.edu/csg/abecasis/metal/). METAL creates a single 
summary P-value for each SNP from all samples together. For each marker, an arbitrary 
reference allele is selected and a Z-statistic, characterizing the evidence for association, is used 
as input. The Z-statistic summarizes the magnitude and the direction of an effect relative to the 
reference allele. An overall Z-statistic and P-value are then calculated from the weighted average 
of the individual statistics. Weights are proportional to the square root of the number of 
individuals examined in each sample, and selected such that the squared weights sum to 1.0. 
Outcomes of the meta-analyses were tested against a Bonferroni corrected threshold of 
significance (P < 0.001). 
 
 
RESULTS 
Primary Sample—IMAGE Cohort 
Most previously reported associations of genes with intelligence included intronic SNPs with no 
clear function. This suggests that they might be controlling RNA signaling networks or that other 
SNPs in LD might be the actual causal variant. We used imputation to increase coverage. We do 
note; however, that even after imputation, not all of the originally reported SNPs were available in the current sample. Of the 15 
candidate genes, six genes showed at least one SNP with a P-value <0.05 (see Table III). 
 
Table III. Results of 15 Candidate Genes for Intelligence in the IMAGE Cohort 
GENE 
Previous 
associated 
SNP (G/I)a 
P-value 
with 
previous 
associated 
SNP 
nSNPs 
tested 
Coverage 
SNP 
density, 
kb/SNP 
nSNPs,P < 0.05 
Most 
significant 
SNP (G/I)a 
Position Type 
BestP-
value 
 
DNAJC13 
rs1378810 
(I) 
0.642 45 1 31.41 0 
rs12637073 
(I) 
133666251 Intronic 0.096 
TBC1D7 
rs2496143 
(I) 
0.8568 47 1 9.20 0 
rs480122 
(G) 
13425063 Intronic 0.588 
DTNBP1 rs1018381 — 65 1 24.55 5 
rs760666 
(G) 
15589121 Intronic 0.020 
ALDH5A1 
rs2760118 
(I) 
0.8328 46 1 13.52 1 
rs2760138 
(I) 
24620816 Intronic 0.047 
IGF2R rs3832385 — 88 0.967 18.62 5 
rs8191898 
(I) 
160418955 Intronic 0.018 
CHRM2 rs8191992 — 81 0.942 21.10 2 
rs6467694 
(G) 
136197456 Upstream 0.010 
GENE 
Previous 
associated 
SNP (G/I)a 
P-value 
with 
previous 
associated 
SNP 
nSNPs 
tested 
Coverage 
SNP 
density, 
kb/SNP 
nSNPs,P < 0.05 
Most 
significant 
SNP (G/I)a 
Position Type 
BestP-
value 
  
rs1378650 
(G) 
0.8284                 
  
rs1424548 
(I) 
0.3888                 
  
rs2350780 
(I) 
0.9788                 
  
rs2350786 
(G) 
0.6316                 
  
rs6948054 
(I) 
0.322                 
  rs7799047 —                 
  rs324640 —                 
  
rs324650 
(I) 
0.2514                 
  rs2061174 —                 
BDNF rs6265 (G) 0.1018 29 1 29.86 2 rs12288512 27704247 Upstream 0.011 
GENE 
Previous 
associated 
SNP (G/I)a 
P-value 
with 
previous 
associated 
SNP 
nSNPs 
tested 
Coverage 
SNP 
density, 
kb/SNP 
nSNPs,P < 0.05 
Most 
significant 
SNP (G/I)a 
Position Type 
BestP-
value 
(I) 
CTSD rs17571 (G) 0.2932 6 1 59.01 0 
rs3740621 
(I) 
1728373 Upstream 0.081 
FADS3 
rs174455 
(I) 
0.6665 9 0.875 41.54 0 
rs174626 
(G) 
61393633 Downstream 0.050 
DRD2 rs2075654 — 57 0.982 15.02 2 
rs4630328 
(I) 
112839419 Intronic 0.047 
KL 
rs9536314 
(G) 
0.6873 52 0.933 13.39 0 
rs17763040 
(G) 
32543384 Intergenic 0.142 
SNAP25 
rs362602 
(G) 
0.2254 71 0.913   0 
rs362990 
(G) 
10224221 Intronic 0.063 
  
rs363039 
(I) 
0.6062                 
  
rs363050 
(G) 
0.3723                 
PRNP 
rs1799990 
(G) 
0.944 21 0.778 20.63 0 
rs6084833 
(I) 
4620759 Intronic 0.135 
GENE 
Previous 
associated 
SNP (G/I)a 
P-value 
with 
previous 
associated 
SNP 
nSNPs 
tested 
Coverage 
SNP 
density, 
kb/SNP 
nSNPs,P < 0.05 
Most 
significant 
SNP (G/I)a 
Position Type 
BestP-
value 
CBS rs5742905 — 22 0.675 19.83 0 
rs1788490 
(I) 
43340620 Intergenic 0.189 
COMT rs4680 (G) 0.6209 33 0.633 14.62 0 
rs9332377 
(I) 
18335692 Intronic 0.08 
Genome build 36. 
a G and I indicate genotyped and imputed SNPs, respectively. 
Of the five previously reported genomic loci (2q24.1-31.1, 2q31.3, 6p25-21.2, 14q11.2-12, and 16p13) investigated here, we observed 
P-values <0.0025 in three regions (6p25-21.2, 2q24.1-31.1, and 14q11.2-12) (see Table IV). Genomic areas 2q31.3 and 16p13.3 
showed no association with IQ (all P-values >0.15). On a SNP level, there were three independent SNPs in intergenic and non-coding 
regions with P-values ≤2.0 × 10−4 inside the 2q24.1-31.1 and 14q11.2-12 areas (Table IV). The lowest P-values were observed for 
rs2807822, P = 1 × 10−4; rs4972741, P = 1.7 × 10−4; and rs6721348 P = 1.8 × 10−4. 
 
 
 
 
 
 
Table IV. Replication Results in the Genomic Loci Previously Associated With Intelligence in the IMAGE Cohort 
SNP (G/I)a Minor/major 
allele 
MAF Rank P-value Chr Position Type Closest 
gene 
Distance 
to gene 
 Genomic location 2q24.1-31.1 (from 154475832 to 177730691 bp) total SNPs tested = 7,819 in 182 genes 
 rs4972741 
(I) G/A 0.12 1 0.00017 2 172823906 Intergenic AC104088.1 −64,355 
 rs6721348 
(I) C/T 0.12 2 0.00018 2 172826755 Intergenic AC104088.1 −61,506 
 rs10172929 
(G) 
G/T 0.13 3 0.00031 2 164756952 Intergenic AC092684.1 0 
 rs16844374 
(G) 
C/T 0.15 7 0.00127 2 160394348 Intronic LY75 0 
 rs10201330 
(I) T/C 0.09 4 0.00132 2 177056271 Intergenic AC017048.3 22,948 
 rs4289149 
(G) A/G 0.18 8 0.00150 2 172834736 Intergenic ITGA6 165,264 
 rs995711 
(G) 
G/T 0.12 5 0.00174 2 164123635 Intergenic FIGN −34,517 
 rs11896469 C/T 0.44 6 0.00230 2 176388492 Intergenic EXTL2P1 27,369 
SNP (G/I)a 
Minor/major 
allele MAF Rank P-value Chr Position Type 
Closest 
gene 
Distance 
to gene 
(G) 
Genomic location 6p25-21.2 (from 5945435 to 41007859 bp) total SNPs tested = 18,651 in 809 genes 
 rs12204969 
(I) 
C/T 0.12 1 0.00018 6 16802156 Intronic ATXN1 0 
 rs17606216 
(G) 
C/T 0.12 2 0.00018 6 16796594 Intronic ATXN1 0 
 rs993600 
(G) 
G/A 0.16 3 0.00027 6 22153623 
Within non-
coding gene 
RP1-
67M12.1 
0 
 rs2023472 
(G) A/G 0.42 4 0.00028 6 30183843 Intergenic TRIM31 5,241 
 rs6929819 
(G) G/A 0.43 5 0.00033 6 33670832 Intergenic C6orf227 1,739 
 rs195371 
(G) 
G/A 0.23 6 0.00034 6 37412364 Intergenic TBC1 3,464- 
 rs6929774 
(I) 
T/C 0.42 7 0.00039 6 33670698 Intergenic C6orf227 1,605 
 rs17606174 T/C 0.13 8 0.00050 6 16795524 Intronic ATXN1 0 
SNP (G/I)a 
Minor/major 
allele MAF Rank P-value Chr Position Type 
Closest 
gene 
Distance 
to gene 
(G) 
Genomic location 14q11.2-12 (from 21269202 to 28322992 bp) total SNPs tested = 2,964 in 233 genes 
 rs2807822 
(I) 
T/C 0.47 1 0.00010 14 27554764 Intergenic AL445384.1 25,600 
 rs3811222 
(I) 
A/G 0.10 2 0.00066 14 22020854 Intronic TRAC 0 
 rs762578 (I) T/G 0.11 3 0.00069 14 22020088 Intronic TRAC 0 
 rs1872159 
(G) T/C 0.09 4 0.00080 14 22017743 Intronic TRAC 0 
 rs7149201 
(I) 
C/T 0.20 5 0.00178 14 23034259 Intergenic NGDN 17,017 
 rs877726 
(G) 
T/A 0.23 6 0.00230 14 27557719 Intergenic AL445384.1 −28,555 
Only SNPs with a P < 0.0025 are shown. 
Genome build 36. 
a G and I indicate genotyped and imputed SNPs, respectively. 
To confirm whether the nominally significant SNPs (P < 0.05) from the candidate genes and the 
top SNPs (P < 0.0025) in each of the genomic regions with IQ were simply due to chance, we 
tested these SNPs in the replication samples. 
 
Replication of Primary Associations in Candidate Genes and Genomic Areas 
We attempted replication in four independent cohorts. We first performed an association analysis 
of the 17 nominally associated SNPs (P-value <0.05) in the candidate genes, and the 22 most 
strongly associated SNPs in the genomic areas in each population (total of 39 SNPs), using the 
same reference allele for each SNP across different populations. The MAF of the tested SNPs 
across the five samples were comparable (see Supplementary Table S1). 
 
We first conducted a combined analysis on only the two samples ascertained for ADHD. We 
then combined all five samples to test whether the significant SNPs were associated with 
intelligence in a general context, or merely in an ADHD background. Although IQ was normally 
distributed in both samples ascertained for ADHD, association of a SNP with IQ in an ADHD 
background may differ from association of that SNP with intelligence in a non-ADHD 
background. 
 
When combining the two samples ascertained for ADHD we found that of all tested SNPs, 12 
had a P-value <0.05 (same direction of effect) of which 6 showed evidence for associated after 
Bonferroni correction (P < 0.001) for multiple testing. For one of these SNPs (rs2807822, 
intergenic, 14q11.2-12), however, the effect was in opposite direction in the two samples 
ascertained for ADHD, also indicated by a significant heterogeneity effect (P = 0.04; see 
Supplementary Table S2). Three other SNPs were in intergenic areas 6p25-21.2 (one SNP) and 
14q11.2-12 (two SNPs), while two SNPs were in genic areas: rs17606174 (P = 0.00018), located 
in the second intron of ATXN1 (ataxin 1) (MIM: 601556), and rs2023472 (P = 0.0003), located 
in exon 5 on TRIM31 (tripartite motif-containing 31) (MIM: 609316). Allelic effect sizes were 
in the order of 3–4 IQ points in the combined DUKE and IMAGE samples. When we combined 
all five samples, none of these associations were significant, even though some of the SNPs 
showed similar direction of effects in some of the replication samples. We provide results in 
Table V. 
 
 
Table V. Meta-Analysis of the Top SNPs From the Primary Analysis 
Gene Genomic 
area 
SNP A 
IMAGE 
(N = 606) 
DUKE 
(N = 216) 
ALSPAC 
(N = 1,495) 
QIMR 
(N = 1,670) 
LBC1936 
(N = 976) 
IMAGE and 
DUKE (N = 822) 
ALL 
(N = 4,963) 
B P B P B P B P B P Z P Z P 
 
Intergenic 
2q24.1-
31.1 rs10172929 T 4.64 0.0003     0.23 0.84 −0.03 0.96 −0.94 0.35     0.95 0.34 
Intergenic 2q24.1-
31.1 
rs10201330 T 5.43 0.0013     1.28 0.27 −0.76 0.38 0.19 0.88     1.32 0.19 
CHRM2 7q33 rs10271552 T −3.18 0.0398     −0.42 0.65 −0.23 0.76 −1.38 0.23     −1.72 0.09 
Intergenic 
2q24.1-
31.1 rs11896469 T 2.55 0.0023     −0.01 0.71 0.47 0.32 −0.38 0.58     1.18 0.24 
ATXN1 6p25-21.2 rs12204969 T 4.98 0.0002     −2.12 0.01 −0.99 0.14 0.49 0.61     0.65 0.51 
BDNF 11p14 rs12273363 T −2.61 0.0131 0.88 0.68 −0.42 0.54 0.13 0.82 0.70 0.43 −2.00 0.0456 0.95 0.34 
BDNF 11p14 rs12288512 A 2.67 0.0114 −0.88 0.68 0.42 0.55 −0.13 0.82 −0.70 0.43 2.04 0.0410 1.32 0.19 
LY75 
2q24.1-
31.1 rs16844374 T 3.77 0.0013                         
ATXN1 6p25-21.2 rs17606174 T −4.47 0.0005 −3.95 0.16 0.12 0.02 0.40 0.53 −0.76 0.41 −3.80 0.0001 −0.22 0.83 
ATXN1 6p25-21.2 rs17606216 T 4.91 0.0002     −2.15 0.01 −0.86 0.20 0.43 0.65     −0.67 0.51 
Gene 
Genomic 
area SNP A 
IMAGE 
(N = 606) 
DUKE 
(N = 216) 
ALSPAC 
(N = 1,495) 
QIMR 
(N = 1,670) 
LBC1936 
(N = 976) 
IMAGE and 
DUKE (N = 822) 
ALL 
(N = 4,963) 
B P B P B P B P B P Z P Z P 
IGF2R 6q26 rs1805075 A −4.47 0.0189     −0.30 0.82 0.76 0.50 −0.62 0.71     −0.73 0.47 
Intergenic 14q11.2-
12 
rs1872159 T 4.77 0.0008 2.61 0.46 −0.30 0.76 0.58 0.43 0.75 0.47 3.32 0.0009 1.92 0.06 
Intergenic 6p25-21.2 rs195371 A −3.65 0.0003     −0.14 0.00 0.62 0.28 −0.23 0.78     −2.41 0.02 
TRIM31 6p25-21.2 rs2023472 A −3.09 0.0003 −1.58 0.35 0.19 0.75 0.95 0.05 0.23 0.73 −3.65 0.0003 −0.25 0.80 
DTNBP1 6p23 rs2619545 T −2.34 0.0362 2.07 0.34 0.25 0.73 −0.34 0.56 0.87 0.30 −1.41 0.1589 −1.98 0.05 
ALDH5A1 6p23 rs2760138 A −3.05 0.0478                         
Intergenic 
14q11.2-
12 
rs2807822 T −3.63 0.0000 0.39 0.82 0.09 0.89 0.77 0.10 −0.19 0.78 −3.34 0.0009 0.54 0.59 
Intergenic 
14q11.2-
12 rs3811222 A 5.15 0.0007 0.91 0.79 −0.47 0.68 0.59 0.41 0.98 0.33 3.16 0.0016 −1.87 0.06 
Intergenic 2q24.1-
31.1 
rs4289149 A 3.36 0.0015 −3.52 0.14 0.00 0.99 1.18 0.05 −0.62 0.48 2.08 0.0380 1.67 0.10 
DRD2 11q23 rs4630328 A −1.79 0.0475     0.95 0.14 0.18 0.71 0.33 0.66     −0.74 0.46 
Intergenic 
2q24.1-
31.1 rs4972741 A −5.51 0.0002     −1.15 0.24 −0.23 0.78 0.80 0.51     −1.87 0.06 
Gene 
Genomic 
area SNP A 
IMAGE 
(N = 606) 
DUKE 
(N = 216) 
ALSPAC 
(N = 1,495) 
QIMR 
(N = 1,670) 
LBC1936 
(N = 976) 
IMAGE and 
DUKE (N = 822) 
ALL 
(N = 4,963) 
B P B P B P B P B P Z P Z P 
CHRM2 7q33 rs6467694 T −3.86 0.0097 −1.47 0.59 0.92 0.32 1.11 0.14 −0.94 0.41 −2.54 0.0112 −0.73 0.47 
DRD2 11q23 rs6589377 A 1.71 0.0504 −0.29 0.87 −0.92 0.13 −0.18 0.71 −0.53 0.46 1.65 0.0986 1.92 0.06 
Intergenic 
2q24.1-
31.1 rs6721348 A −5.51 0.0002     −1.09 0.26 −0.28 0.73 0.79 0.51     0.04 0.97 
Intergenic 6p25-21.2 rs6929774 T −3.09 0.0004 1.98 0.23 0.05 0.18 −0.63 0.19 0.43 0.53 −2.62 0.0089 −0.77 0.44 
C6orf227 6p25-21.2 rs6929819 A 3.08 0.0003 −1.09 0.26 −0.05 0.20 0.65 0.18 −0.41 0.55 2.65 0.0081 0.86 0.39 
Intergenic 
14q11.2-
12 rs7149201 T 3.72 0.0018 −2.30 0.42 0.36 0.62 −0.39 0.49 0.49 0.54 2.45 0.0144 1.10 0.27 
DTNBP1 6p23 rs760666 A −2.34 0.0223 0.87 0.69 −0.33 0.64 0.13 0.81 −0.11 0.90 −1.85 0.0644 −0.91 0.36 
Intergenic 
14q11.2-
12 rs762578 T 4.62 0.0007 2.32 0.40 −0.31 0.73 0.73 0.29 0.27 0.79 3.40 0.0007 1.89 0.06 
DTNBP1 6p23 rs7758659 T −2.34 0.0225 0.88 0.69 −0.34 0.63 0.13 0.81 −0.11 0.89 −1.85 0.0648 −0.91 0.36 
IGF2R 6q26 rs8191818 T −4.49 0.0200 −2.79 0.35 −0.36 0.80 0.65 0.56 −0.47 0.78 −2.49 0.0126 −0.92 0.36 
IGF2R 6q26 rs8191821 T 4.52 0.0196 2.79 0.35 0.34 0.80 −0.65 0.56 0.47 0.78 2.50 0.0124 0.92 0.36 
IGF2R 6q26 rs8191898 T 4.47 0.0185 2.78 0.35 0.31 0.82 −0.76 0.50 0.47 0.78 2.52 0.0117 0.86 0.39 
Gene 
Genomic 
area SNP A 
IMAGE 
(N = 606) 
DUKE 
(N = 216) 
ALSPAC 
(N = 1,495) 
QIMR 
(N = 1,670) 
LBC1936 
(N = 976) 
IMAGE and 
DUKE (N = 822) 
ALL 
(N = 4,963) 
B P B P B P B P B P Z P Z P 
DTNBP1 6p23 rs875462 T 2.21 0.0318 −1.20 0.57 0.39 0.57 −0.17 0.76 0.59 0.47 1.64 0.1012 1.11 0.27 
Intergenic 14q11.2-
12 
rs877726 A −3.09 0.0023 −0.55 0.79 0.00 0.92 0.65 0.23 −0.41 0.59 −2.75 0.0059 −0.67 0.50 
DTNBP1 6p23 rs9296983 A −2.33 0.0229 0.87 0.69 −0.33 0.64 0.16 0.77 −0.11 0.90 −1.84 0.0657 1.10 0.27 
IGF2R 6q26 rs9457827 T 4.47 0.0187 2.78 0.35 0.30 0.82 −0.76 0.50 0.62 0.71 2.52 0.0119 0.89 0.37 
Non-coding 
gene 
6p25-21.2 rs993600 A 4.11 0.0003 1.41 0.49 0.33 0.67 0.00 0.99 0.13 0.88 3.55 0.0004 1.71 0.09 
Intergenic 
2q24.1-
31.1 rs995711 T 4.02 0.0018 2.16 0.44 1.19 0.25 −0.67 0.40 0.27 0.84 3.15 0.0017 1.47 0.14 
A is the reference allele; B is the beta effect; P is the P-value, Z is the Z-statistic as provided in the meta-analysis. 
Bold indicates below the Bonferroni corrected threshold of significance (<0.001) and same direction of effect in the meta-analysis. 
DISCUSSION 
This study aimed to replicate association of previously reported candidate genes for IQ as well as to fine-map previously linked 
genomic areas. As available samples differed in ascertainment method (i.e., ascertained for ADHD or population based) we tested for 
SNP associations with IQ in an ADHD background and in a non-ADHD, general population, background. 
In the primary analysis, we found weak evidence for the association of some of the 
previously reported genes with IQ: IGF2R (five SNPs with P-value <0.05), DTNBP1 
(five SNPs with P-value <0.05), ALDHA5A1 (one SNP with P-value <0.05), BDNF (two 
SNPs with P-value <0.05), DRD2 (two SNPs with P-value <0.05), and CHRM2 (two 
SNPs with P-value ≤0.03). None of SNPs previously associated with IQ showed 
association in the current study (P-value >0.05). The lack of replication can either 
indicate a false positive finding in previous studies, or might be explained by the 
ascertainment for ADHD in our primary sample. Although association between IQ and 
ADHD in the current sample was not significant, and IQ was distributed normally in the 
IMAGE sample, previous reports [e.g., Kuntsi et al., 2004] do indicate a (genetic) 
association between ADHD and IQ. 
Results from the primary association analysis in the genomic loci implicated three 
intergenic regions (2q24.1-31, 6p25-21.2, and 14q11.2-12). The nominally significant 
SNPs from the candidate genes, and the top SNPs from the genomic regions, were 
included in a stepwise combined analysis. When we combined the two samples 
ascertained for ADHD (totaling 822 subjects), we found that five SNPs were associated 
with IQ. None of these SNPs were inside candidate genes previously implicated, but 
instead were located in two genomic areas: 6p25-21.2 and 14q11.2-12. Two of these 
SNPs were inside two genes: rs17606174 was in the second intron of the ATXN1 gene, 
and rs2023472 in exon 5 on TRIM31. However, when we combined all samples, none of 
these SNPs showed a significant association with intelligence. However, we cannot 
exclude the possibility of type I error given the total number of tests performed within the 
discovery sample only. These results provide suggestive evidence that the ATXN1 and 
TRIM31 genes, and several other SNPs in areas 6p25-21.2 and 14q11.2-12, are related to 
IQ, but only on the background of ADHD. 
 
In the primary IMAGE association results, ATXN1 has 25 SNPs with P-value <0.05, and 
most of them are located in the second intron of ATXN1, nearby an alternative splicing 
region. ATXN1 is present in the nucleus of the neurons of the basal ganglia, pons and 
cortex, and in both cytoplasm and nucleus of Purkinje cells of the cerebellum [Servadio et 
al., 1995]. Expansion of a (CAG)n repeat in ATXN1 (previous called SCA1 gene) causes 
spinocerebellar ataxia-1 (SCA1) in humans (MIM: 164400) [Orr et al., 1993; Banfi et al., 
1994]. It was also reported that mice lacking ATXN1 are characterized by decreased 
exploratory behavior, pronounced deficits in the spatial version of the Morris water maze 
test, and impaired performance on the rotating rod apparatus [Matilla et al., 1998], 
pointing to the possible role of ATXN1 in learning and memory. 
 
In the primary IMAGE association results, TRIM31 has 23 SNPs with P-value <0.05 and 
most of them are located in the 5′ region and in intron 1 of TRIM31. The protein encoded 
by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes 
three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil 
region [Meroni and Diez-Roux, 2005]. Other members of the TRIM family (TRIM3, 
MIM: 605493) were reported to modulate NGF-induced neurite outgrowth in PC12 cells 
[El-Husseini and Vincent, 1999]. 
 
In summary, we found very little support for genetic variants in genes that have 
previously been associated with intelligence. In addition, this study did provide tentative 
support for a role of the ATXN1 and TRIM31 genes in previously associated linkage 
areas for intelligence in the context of a psychiatric disorder, that is, ADHD. This 
suggests that genetic variants important for IQ in a non-psychiatric population may not 
necessary overlap with genetic variants important for IQ in a psychiatric population. 
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Table S1. Minor allele frequencies across samples of the SNPs included in the replication 
analysis.  
GENE Genomic area SNP 
MAJOR/MIN
OR 
MAF_IMA
GE 
MAF_DU
KE 
MAF_ALSP
AC 
MAF_QI
MR 
MAF_LBC1
936 
Intergeni
c 
2q24.1-
31.1 
rs101729
29 T/G 0.1399  0.1354 0.1183 0.1245 
Intergeni
c 
2q24.1-
31.1 
rs102013
30 C/T 0.09  0.0974 0.07907 0.07326 
CHRM2 7q33 rs10271552 T/C 0.091  0.1062 0.1044 0.09785 
Intergeni
c 
2q24.1-
31.1 
rs118964
69 T/C 0.4472  0.44 0.4266 0.4175 
ATXN1 6p25-21.2 
rs122049
69 T/C 0.1217  0.1358 0.1303 0.1383 
BDNF 11p14 rs12273363 T/C 0.192 0.2201 0.2185 0.2026 0.1967 
BDNF 11p14 rs12288512 G/A 0.1962 0.2199 0.2184 0.2025 0.1967 
LY75 2q24.1-31.1 
rs168443
74 T/C 0.15     
ATXN1 6p25-21.2 
rs176061
74 C/T 0.1346 0.1113 0.15 0.1458 0.1568 
ATXN1 6p25-21.2 
rs176062
16 T/C 0.1229  0.1365 0.1297 0.1368 
IGF2R 6q26 rs1805075 A/G 0.0594  0.0515 0.04628 0.04508 
Intergeni 14q11.2- rs187215 C/T 0.098 0.1258 0.1075 0.1135 0.1265 
c 12 9 
Intergeni
c 
6p25-
21.2 rs195371 A/G 0.2341  0.22 0.2167 0.208 
TRIM31 6p25-21.2 
rs202347
2 G/A 0.4212 0.3889 0.395 0.4089 0.3934 
DTNBP
1 6p23 
rs261954
5 T/C 0.2058 0.1871 0.2085 0.2017 0.208 
ALDH5
A1 6p23 
rs276013
8 A/G 0.1016     
Intergeni
c 
14q11.2-
12 
rs280782
2 C/T 0.4753 0.4449 0.4701 0.4901 0.4672 
Intergeni
c 
14q11.2-
12 
rs381122
2 G/A 0.1045 0.1252 0.1071 0.1139 0.1358 
Intergeni
c 
2q24.1-
31.1 
rs428914
9 G/A 0.18 0.1775 0.19 0.1886 0.1814 
DRD2 11q23 rs4630328 G/A 0.3698  0.3538 0.3517 0.3294 
Intergeni
c 
2q24.1-
31.1 
rs497274
1 A/G 0.1216  0.0958 0.09398 0.0835 
CHRM2 7q33 rs6467694 T/C 0.0939 0.1202 0.1027 0.1046 0.0958 
DRD2 11q23 rs6589377 A/G 0.386 0.3643 0.3826 0.3705 0.3463 
Intergeni
c 
2q24.1-
31.1 
rs672134
8 A/G 0.1216  0.0971 0.09448 0.0835 
Intergeni
c 
6p25-
21.2 
rs692977
4 C/T 0.4274 0.4575 0.45 0.4652 0.4657 
C6orf22
7 
6p25-
21.2 
rs692981
9 A/G 0.435 0.4653 0.4673 0.4675 0.4667 
Intergeni
c 
14q11.2-
12 
rs714920
1 T/C 0.1935 0.1968 0.2229 0.2287 0.2269 
DTNBP
1 6p23 rs760666 G/A 0.2471 0.2254 0.2168 0.2355 0.2136 
Intergeni
c 
14q11.2-
12 rs762578 G/T 0.1141 0.1353 0.1231 0.1289 0.1424 
DTNBP
1 6p23 
rs775865
9 C/T 0.2478 0.2254 0.2169 0.2355 0.2136 
IGF2R 6q26 rs8191818 T/G 0.0537 0.0859 0.0504 0.04623 0.04508 
IGF2R 6q26 rs8191821 C/T 0.0542 0.086 0.0505 0.04623 0.04508 
IGF2R 6q26 rs8191898 C/T 0.0596 0.087 0.0514 0.04628 0.04508 
DTNBP
1 6p23 rs875462 T/C 0.2518 0.24 0.2321 0.2353 0.2223 
Intergeni
c 
14q11.2-
12 rs877726 A/T 0.2351 0.263 0.27 0.257 0.2649 
DTNBP
1 6p23 
rs929698
3 G/A 0.2471 0.2253 0.2168 0.2351 0.2136 
IGF2R 6q26 rs9457827 C/T 0.0595 0.0872 0.0515 0.04628 0.04508 
Noncodi
ng gene 
6p25-
21.2 rs993600 A/G 0.1689 0.2204 0.1702 0.1969 0.1926 
Intergeni
c 
2q24.1-
31.1 rs995711 T/G 0.1253 0.1315 0.1174 0.09851 0.09324 
 
Table S2. Heterogeneity tests in the meta-analysis.  
GENE Genomic area SNP 
IMAGE & DUKE ALL 
N=822 N=4963 
HetChiSq HetDf HetPVal HetChiSq HetDf HetPVal 
Intergenic 2q24.1-31.1 rs10172929    13.034 3 0.004563 
Intergenic 2q24.1-31.1 rs10201330    10.61 3 0.01403 
CHRM2 7q33 rs10271552    3.034 3 0.3864 
Intergenic 2q24.1-31.1 rs11896469    9.254 3 0.0261 
ATXN1 6p25-21.2 rs12204969    22.261 3 5.76E-05 
BDNF 11p14 rs12273363 2.328 1 0.127 6.973 4 0.1373 
BDNF 11p14 rs12288512 2.399 1 0.1214 7.192 4 0.1261 
LY75 2q24.1-31.1 rs16844374       
ATXN1 6p25-21.2 rs17606174 0.136 1 0.7123 20.672 4 0.000368 
ATXN1 6p25-21.2 rs17606216    21.996 3 6.54E-05 
IGF2R 6q26 rs1805075    5.637 3 0.1307 
Intergenic 14q11.2-12 rs1872159 0.669 1 0.4132 9.255 4 0.05504 
Intergenic 6p25-21.2 rs195371    16.831 3 0.000766 
TRIM31 6p25-21.2 rs2023472 0.742 1 0.3889 18.243 4 0.001106 
DTNBP1 6p23 rs2619545 3.324 1 0.06826 6.794 4 0.1472 
ALDH5A1 6p23 rs2760138       
Intergenic 14q11.2-12 rs2807822 4.077 1 0.04348 17.763 4 0.001373 
Intergenic 14q11.2-12 rs3811222 1.655 1 0.1982 9.737 4 0.0451 
Intergenic 2q24.1-31.1 rs4289149 7.551 1 0.005998 13.734 4 0.008196 
DRD2 11q23 rs4630328    6.126 3 0.1056 
Intergenic 2q24.1-31.1 rs4972741    12.511 3 0.005822 
CHRM2 7q33 rs6467694 0.543 1 0.4611 10.805 4 0.02884 
DRD2 11q23 rs6589377 1.127 1 0.2885 6.344 4 0.1749 
Intergenic 2q24.1-31.1 rs6721348    12.302 3 0.006418 
Intergenic 6p25-21.2 rs6929774 7.189 1 0.007335 17.342 4 0.001659 
C6orf227 6p25-21.2 rs6929819 7.124 1 0.007606 17.253 4 0.001726 
Intergenic 14q11.2-12 rs7149201 4.41 1 0.03573 10.292 4 0.03578 
DTNBP1 6p23 rs760666 1.958 1 0.1617 4.851 4 0.303 
Intergenic 14q11.2-12 rs762578 0.645 1 0.4219 9.944 4 0.04139 
DTNBP1 6p23 rs7758659 1.954 1 0.1622 4.834 4 0.3047 
IGF2R 6q26 rs8191818 0.071 1 0.7902 5.932 4 0.2043 
IGF2R 6q26 rs8191821 0.073 1 0.7869 5.963 4 0.2019 
IGF2R 6q26 rs8191898 0.079 1 0.7786 6.294 4 0.1783 
DTNBP1 6p23 rs875462 2.246 1 0.134 4.642 4 0.326 
Intergenic 14q11.2-12 rs877726 1.309 1 0.2526 10.634 4 0.031 
DTNBP1 6p23 rs9296983 1.945 1 0.1631 4.888 4 0.299 
IGF2R 6q26 rs9457827 0.078 1 0.7799 6.262 4 0.1804 
Noncoding gene 6p25-21.2 rs993600 1.182 1 0.277 11.019 4 0.02635 
Intergenic 2q24.1-31.1 rs995711 0.495 1 0.4817 10.277 4 0.036 
 
 
 
 
